Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue SUPPL. 3, 2011, Pages

  Bermúdez Aza, Elkin Hernan ^a   Kerr, Ligia Regina Franco Sansigolo ^b   Kendall, Carl ^c   Pinho, Adriana Araujo ^d   De Mello, Maeve Brito ^d   Mota, Rosa Salani ^b   Guimarães, Mark Drew Crosland ^e   Alencar, Cecilia Salete ^a,d   De Brito, Ana Maria ^f   Dourado, Ines Costa ^g   Da Batista, Sonia Maria Batista ^h   Abreu, Fabiano ⁱ   De Oliveira, Lisangela Cristina ^j   De Souza Moraes, Adão ^k   Benzaken, Adele Schwartz ^f   Merchan Hamann, Edgar ^l   De Freitas, Gisele Maria Brandão ^m   McFarland, Willi ⁿ   Albuquerque, Elizabeth ^d   Rutherford, George W ⁿ   Sabino, Ester ^a,o   more..

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c TULANE UNIVERSITY   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h Secretaria Municipal de Saúde de Santos   (Brazil)

ⁱ UNIVERSIDADE CAMILO CASTELO BRANCO   (Brazil)

^j Secretaria Municipal de Saúde de Itajái   (Brazil)

^k Uni Brasil ^*  (Brazil)

^l UNIVERSITY OF BRASILIA   (Brazil)

^m Secretaria Municipal de Saúde de Campo Grande   (Brazil)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

antiretroviral resistance; Brazil; HIV 1; men who have sex with men; respondent driven sampling

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BRAZIL; CLADISTICS; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS MUTATION;

ADULT; AMINO ACID SUBSTITUTION; ANTI-RETROVIRAL AGENTS; BRAZIL; CLUSTER ANALYSIS; DATA COLLECTION; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; URBAN POPULATION;

EID: 79960777441     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821e9c36     Document Type: Article

References (33)

1. Dumans AT, Soares MA, Machado ES, et al. Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. J Infect Dis. 2004;189:1232-1238. (Pubitemid 38457248)
2. Brigido LF, Nunes CC, Oliveira CM, et al. HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. AIDS Res Hum Retroviruses. 2007;23:1579-1586.
3. Santos AF, Schrago CG, Martinez AM, et al. Epidemiologic and evolutionary trends of HIV-1 CRF31-BC-related strains in southern Brazil. J Acquir Immune Defic Syndr. 2007;45:328-333.
4. Deeks SG, Gange SJ, Kitahata MM, et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009;49: 1582-1590.
5. Jakobsen MR, Tolstrup M, Sogaard OS, et al. Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome. Clin Infect Dis. 2010;50:566-573.
6. Moreno S, Lopez Aldeguer J, Arribas JR, et al. The future of antiretroviral therapy: challenges and needs. J Antimicrob Chemother. 2010;65: 827-835.
7. Nunn AS, Fonseca EM, Bastos FI, et al. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Med. 2007;4:e305.
8. Machado ES, Afonso AO, Nissley DV, et al. Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child. PLoS One. 2009;4:e4806.
9. Booth CL, Geretti AM. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. J Antimicrob Chemother. 2007;59:1047-1056. (Pubitemid 47073314)
10. Vercauteren J, Wensing AM, van de Vijver DA, et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis. 2009;200: 1503-1508.
11. Kijak GH, Pampuro SE, Avila MM, et al. Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina. Antivir Ther. 2001;6:71-77. (Pubitemid 33704484)
12. DiazGranados CA, Mantilla M, Lenis W. Antiretroviral drug resistance in HIV-infected patients in Colombia. Int J Infect Dis. 2010;14:e298-e303.
13. Perez L, Alvarez LP, Carmona R, et al. Genotypic resistance to antiretroviral drugs in patients infected with several HIV type 1 genetic forms in Cuba. AIDS Res Hum Retroviruses. 2007;23:407-414. (Pubitemid 46608561)
14. Brindeiro RM, Diaz RS, Sabino EC, et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS. 2003;17:1063-1069. (Pubitemid 36549719)
15. Soares MA, Brindeiro RM, Tanuri A. Primary HIV-1 drug resistance in Brazil. AIDS. 2004;18(suppl 3):S9-S13. (Pubitemid 39037453)
16. Barreto CC, Nishyia A, Araujo LV, et al. Trends in antiretroviral drug resistance and clade distributions among HIV-1-infected blood donors in Sao Paulo, Brazil. J Acquir Immune Defic Syndr. 2006;41:338-341.
17. Pedroso C, Queiroz AT, Alcantara LC, et al. High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil. J Acquir Immune Defic Syndr. 2007;45: 251-253. (Pubitemid 46869822)
18. Sucupira MC, Caseiro MM, Alves K, et al. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS. 2007;21:116-128. (Pubitemid 46394455)
19. Inocencio LA, Pereira AA, Sucupira MC, et al. Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc. 2009;12:20.
20. Gorbach PM, Drumright LN, Javanbakht M, et al. Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2008;47:639-643. (Pubitemid 351442022)
21. Yerly S, Junier T, Gayet-Ageron A, et al. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS. 2009;23:1415-1423.
22. Baral S, Sifakis F, Cleghorn F, et al. Elevated risk for HIV infection among men who have sex with men in low-and middle-income countries 2000-2006: a systematic review. Plos Med. 2010;4:e339.
23. Magnani R, Sabin K, Saidel T, et al. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(suppl 2): S67-S72.
24. Goel S, Salganik MJ. Assessing respondent-driven sampling. Proc Natl Acad Sci USA. 2010;107:6743-6747.
25. Kendall C, Kerr LR, Gondim RC, et al. An empirical comparison of respondent-driven sampling, time location sampling, and snowball sampling for behavioral surveillance in men who have sex with men, Fortaleza, Brazil. AIDS Behav. 2008;12(suppl):S97-S104.
26. Sa Filho DJ, Sanabani S, Diaz RS, et al. Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil. AIDS Res Hum Retroviruses. 2005;21:145-151. (Pubitemid 40354356)
27. Araujo LV, Soares MA, Oliveira SM, et al. DBCollHIV: a database system for collaborative HIV analysis in Brazil. Genet Mol Res. 2006; 5:203-215.
28. Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724.
29. Ferreira JL, Thomaz M, Rodrigues R, et al. Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. Mem Inst Oswaldo Cruz. 2008;103:800-808.
30. Rodrigues R, Scherer LC, Oliveira CM, et al. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Virus Res. 2006;116:201-207. (Pubitemid 43221733)
31. Sprinz E, Netto EM, Patelli M, et al. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses. 2009;25:861-867.
32. Walter H, Low P, Harrer T, et al. No evidence for persistence of multidrugresistant viral strains after a 7-month treatment interruption in an HIV-1-infected individual. J Acquir Immune Defic Syndr. 2002;31:137-146. (Pubitemid 35190567)
33. Hance AJ, Lemiale V, Izopet J, et al. Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J Virol. 2001;75:6410-6417. (Pubitemid 32578160)